FIELD: medicine.
SUBSTANCE: invention relates to the use of sulfonates of formula (I) for the inhibition of human lactate dehydrogenase A:
.
EFFECT: inhibition of human lactate dehydrogenase A.
1 cl, 1 dwg, 1 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
IRREVERSIBLE INHIBITOR OF SARCOPLASMIC RETICULUM Ca-ADENOSINE TRIPHOSPHATASE | 2001 |
|
RU2194756C1 |
METHOD OF PRODUCTION OF POLYELECTROLYTE NANO- AND MICROCAPSULES WITH PROTEIN CONTENT | 2007 |
|
RU2369386C2 |
MICRODIAGNOSTICUM AND A METHOD FOR ENZYMATIC DETERMINATION OF CONCENTRATION OF A SUBSTANCE BEING ANALYZED | 2006 |
|
RU2316769C1 |
STRAIN OF BACTERIA SALMONELLA TYPHIMURIUM B-14359, RESISTANT TO SULPHONYLUREAS AND TRIAZOLE PYRIMIDINES, FOR DETECTION OF POTENTIAL MUTAGENICITY OF CHEMICALS IN AMES TEST | 2023 |
|
RU2814258C1 |
POLYPEPTIDES FOR TREATING ONCOLOGICAL DISEASES | 2017 |
|
RU2728870C2 |
DRUG FOR TREATMENT OF BENIGN AND MALIGNANT TUMOR DISEASE COMPRISING DERIVATIVE OF DYSORAZOL | 2003 |
|
RU2322236C2 |
METHOD FOR EVALUATION OF POTENTIAL MUTAGENICITY OF SULPHONYLUREAS AND TRIAZOLPYRIMIDINES USING THE AMES TEST ON INDICATOR SALMONELLA TYPHIMURIUM STRAINS | 2022 |
|
RU2794797C1 |
METHOD OF MODULATION OF EICOSANOID METABOLISM | 2006 |
|
RU2438684C2 |
SELECTIVE INHIBITORS OF GLYCERALDEHYDE-3-PHOSPHATEDEHYDROGENASE OF MICROBACTERIA | 2017 |
|
RU2661151C1 |
IRREVERSIBLE INHIBITOR OF [H, K]-ADENOSINE TRIPHOSPHATASE | 2001 |
|
RU2186108C1 |
Authors
Dates
2021-07-07—Published
2020-07-29—Filed